Status:
COMPLETED
Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
University Hospital, Angers
Centre Hospitalier le Mans
Conditions:
Hypoparathyroidism
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. The hypothesis of the investigators is that the mental health is impaired in hypoparathyroid patients c...
Detailed Description
Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. In this retrospective, observational, multicentre study, the investigators evaluated the quality of lif...
Eligibility Criteria
Inclusion
- Patients operated of total thyroidectomy
- Patients suffering from persistent hypoparathyroidism defined as serum PTH inferior to 15 pg/mL 6 months after the surgery, requiring vitamin-calcic supplementation.
- Age superior to 18
- Answering the survey
Exclusion
- Pregnancy at the time of the study
- Age inferior to 18 or adult under guardianship
- Patients with vitamino-calcic supplementation without serum PTH measurement
- Cause of hypoparathyroidism other than post-operatory.
Key Trial Info
Start Date :
February 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 24 2020
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04053647
Start Date
February 5 2020
End Date
June 24 2020
Last Update
August 7 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49100
2
Centre Hospitalier Le Mans
Le Mans, France, 72037
3
CHU Limoges
Limoges, France, 87042
4
CHU Nancy
Nancy, France, 54511